https://www.gsk.com/en-gb/media/press-releases/regulatory-update-albiglutide-us-pdufa-date-extended-by-three-months/
Regulatory update: albiglutide US PDUFA date extended by three months | GSK
GSK announced that PDUFA goal date for albiglutide, treatment for adult patients with type 2 diabetes, has been extended by three months.
regulatory updateextended bythree monthsalbiglutideus
https://www.goodrx.com/tanzeum/what-is
Albiglutide: Drug Basics and Frequently Asked Questions
Learn about albiglutide, including frequently asked questions about the medication.
frequently askedalbiglutidedrugbasicsquestions
https://www.news-medical.net/news/2009/02/18/45982.aspx
GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication
Jun 18, 2019 - GlaxoSmithKline has announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and...
phase iii trialtype 2 diabetes